Physician profile
Christopher A Walter
NPI 1447420732
$12,268.80
in general payments reported to CMS, 2019-2025
11 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,130 · 2021: $3,598 · 2022: $66.00 · 2023: $1,662 · 2024: $5,421 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,521 · Food and Beverage: $2,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,520.73 |
| Food and Beverage | $2,953.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,440.00 | 2021-2025 | Persona, Avenir, Rosa |
| Evolution Surgical, INC | $4,762.17 | 2020-2023 | |
| Arthrex, INC. | $1,340.82 | 2021-2023 | Distal Extremities Implants Trauma |
| Stryker Corporation | $176.54 | 2023-2025 | Variax |
| Osteoremedies, LLC | $174.82 | 2025 | Remedy Spacer, Osteoboost Select 5cc, Remedy Spectrum Gv Spacer |
| Miach Orthopaedics, INC. | $158.32 | 2023 | |
| Depuy Synthes Sales INC. | $130.20 | 2022-2024 | Na |
| Merck Sharp & Dohme LLC | $30.66 | 2024 | Bridion |
| Smith+Nephew, INC. | $25.02 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Heron Therapeutics, INC. | $17.54 | 2024 | Zynrelef |
| Forte Bio-Pharma LLC | $12.71 | 2023 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.